Literature DB >> 27836987

RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice.

Hiroyuki Kanzaki1,2, Fumiaki Shinohara3, Kanako Itohiya2, Yuuki Yamaguchi2, Yuta Katsumata2, Masazumi Matsuzawa2, Sari Fukaya2, Yutaka Miyamoto2, Satoshi Wada2, Yoshiki Nakamura2.   

Abstract

Reactive oxygen species (ROS) play a role in intracellular signaling during osteoclastogenesis. We previously reported that transcriptional factor nuclear factor E2-related factor 2 (Nrf2) was exported from the nucleus to the cytoplasm by receptor activator of nuclear factor-κB ligand (RANKL), and that Nrf2 negatively regulated osteoclastogenesis via antioxidant enzyme up-regulation. Knockout mice of BTB and CNC homology 1 (Bach1)-the competitor for Nrf2 in transcriptional regulation-was known to attenuate RANKL-mediated osteoclastogenesis, although the mechanism remains unclear. Therefore, we hypothesized that RANKL could be involved in the nuclear translocation of Bach1, which would attenuate Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular ROS signaling in osteoclasts. RANKL induced Bach1 nuclear import and Nrf2 nuclear export. Induction of Bach1 nuclear export increased Nrf2 nuclear import, augmented antioxidant enzyme expression, and, thus, diminished RANKL-mediated osteoclastogenesis via attenuated intracellular ROS signaling. Finally, an in vivo mouse bone destruction model clearly demonstrated that induction of Bach1 nuclear export inhibited bone destruction. In this study, we report that RANKL favors osteoclastogenesis via attenuation of Nrf2-mediated antioxidant enzyme expression by competing with Bach1 nuclear accumulation. Of importance, induction of Bach1 nuclear export activates Nrf2-dependent antioxidant enzyme expression, thereby attenuating osteoclastogenesis. Bach1 nuclear export might be a therapeutic target for such bone destructive diseases as rheumatoid arthritis, osteoporosis, and periodontitis.-Kanzaki, H., Shinohara, F., Itohiya, K., Yamaguchi, Y., Katsumata, Y., Matsuzawa, M., Fukaya, S., Miyamoto, Y., Wada, S., Nakamura, Y. RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice. © FASEB.

Entities:  

Keywords:  JNK; NQO1; aminolevulinic acid; bone destruction; heme

Mesh:

Substances:

Year:  2016        PMID: 27836987     DOI: 10.1096/fj.201600826R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

1.  Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss.

Authors:  Ciro Menale; Lisa J Robinson; Eleonora Palagano; Rosita Rigoni; Marco Erreni; Alejandro J Almarza; Dario Strina; Stefano Mantero; Michela Lizier; Antonella Forlino; Roberta Besio; Marta Monari; Paolo Vezzoni; Barbara Cassani; Harry C Blair; Anna Villa; Cristina Sobacchi
Journal:  J Bone Miner Res       Date:  2019-09-09       Impact factor: 6.741

2.  CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.

Authors:  Peng Xue; Xiangxiang Hu; James Powers; Nicole Nay; Emily Chang; Jane Kwon; Sing Wai Wong; Lichi Han; Tai-Hsien Wu; Dong-Joon Lee; Henry Tseng; Ching-Chang Ko
Journal:  Biochem Biophys Res Commun       Date:  2019-02-27       Impact factor: 3.575

Review 3.  BACH transcription factors in innate and adaptive immunity.

Authors:  Kazuhiko Igarashi; Tomohiro Kurosaki; Rahul Roychoudhuri
Journal:  Nat Rev Immunol       Date:  2017-05-02       Impact factor: 53.106

4.  Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.

Authors:  Yuuki Yamaguchi; Hiroyuki Kanzaki; Yuta Katsumata; Kanako Itohiya; Sari Fukaya; Yutaka Miyamoto; Tsuyoshi Narimiya; Satoshi Wada; Yoshiki Nakamura
Journal:  J Cell Mol Med       Date:  2017-10-24       Impact factor: 5.310

Review 5.  Pathways that Regulate ROS Scavenging Enzymes, and Their Role in Defense Against Tissue Destruction in Periodontitis.

Authors:  Hiroyuki Kanzaki; Satoshi Wada; Tsuyoshi Narimiya; Yuuki Yamaguchi; Yuta Katsumata; Kanako Itohiya; Sari Fukaya; Yutaka Miyamoto; Yoshiki Nakamura
Journal:  Front Physiol       Date:  2017-05-30       Impact factor: 4.566

6.  18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK-TRAF6 Interactions and NF-κB and MAPK Signaling Pathways.

Authors:  Xiao Chen; Xin Zhi; Zhifeng Yin; Xiaoqun Li; Longjuan Qin; Zili Qiu; Jiacan Su
Journal:  Front Pharmacol       Date:  2018-06-20       Impact factor: 5.810

7.  Magnolol prevents ovariectomy‑induced bone loss by suppressing osteoclastogenesis via inhibition of the nuclear factor‑κB and mitogen‑activated protein kinase pathways.

Authors:  Wen-Yong Fei; Qiang Huo; Pei-Qing Zhao; Long-Juan Qin; Tao Li
Journal:  Int J Mol Med       Date:  2019-02-18       Impact factor: 4.101

8.  Nrf2 activation in osteoblasts suppresses osteoclastogenesis via inhibiting IL-6 expression.

Authors:  Tsuyoshi Narimiya; Hiroyuki Kanzaki; Yuki Yamaguchi; Satoshi Wada; Yuta Katsumata; Ken Tanaka; Hiroshi Tomonari
Journal:  Bone Rep       Date:  2019-11-01

9.  Guaiacol suppresses osteoclastogenesis by blocking interactions of RANK with TRAF6 and C-Src and inhibiting NF-κB, MAPK and AKT pathways.

Authors:  Xin Zhi; Chao Fang; Yanqiu Gu; Huiwen Chen; Xiaofei Chen; Jin Cui; Yan Hu; Weizong Weng; Qirong Zhou; Yajun Wang; Yao Wang; Hao Jiang; Xiaoqun Li; Liehu Cao; Xiao Chen; Jiacan Su
Journal:  J Cell Mol Med       Date:  2020-03-17       Impact factor: 5.310

Review 10.  Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2.

Authors:  Chia-Hung Yen; Chin-Mu Hsu; Samuel Yien Hsiao; Hui-Hua Hsiao
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.